about
Cell-free DNA as a diagnostic marker for cancer: current insightsCirculating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone.miR-17-92a-1 cluster host gene (MIR17HG) evaluation and response to neoadjuvant chemoradiotherapy in rectal cancer.Cell-free DNA detected by "liquid biopsy" as a potential prognostic biomarker in early breast cancer.Impact of Candidate Genetic Polymorphisms in Prostate Cancer: An Overview.Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.The potential use of urine cell free DNA as a marker for cancer.Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.Digital PCR identifies changes in CDH1 (E-cadherin) transcription pattern in intestinal-type gastric cancer.Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.Vitamin D status among long-term survivors of testicular cancer.GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic ImplicationsUrine cell-free DNA integrity as a marker for early prostate cancer diagnosis: a pilot study.Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients.Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs.Serum and Plasma Copy Number Detection Using Real-time PCR.AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer.Detection of a CDH1 Rare Transcript Variant in Fresh-frozen Gastric Cancer Tissues by Chip-based Digital PCR.GSTP1 methylation in cancer: a liquid biopsy biomarker?Cell-Free DNA Integrity Analysis in Urine Samples.CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.Plasma AR and abiraterone-resistant prostate cancer.Association among metabolic syndrome, inflammation, and survival in prostate cancer
P50
Q28074556-D1B4937E-61B2-4BE8-83AD-829AEB7C41C5Q35603660-54D3D1E7-D566-46C7-8A7F-3CAE584CDF94Q36900550-0B30A0C5-3049-489B-BD3F-9324B02BFCF2Q37725496-29220839-3C5D-457A-A21E-C3E7E36EF081Q38620751-0A71AA0E-9130-4720-AB09-75E6454CBBA9Q38804089-17673162-C4D3-44AA-9484-D54FE88D281DQ38827364-94140164-B313-4F4C-A06A-3D0FEEEA44B2Q38833996-03B0112C-2C45-47BF-B1A9-F3106033C1E1Q38994581-DFED4703-09C8-4586-990F-43A671532788Q40374954-92D512F6-403D-4132-AF02-43928A2C193FQ40421665-6DB8F279-8540-4C76-8E84-EFFA1A7F53E3Q40985522-A71F4235-1A6E-4560-A48D-D5D3BCA06CA5Q41055710-6657A91A-A0BE-4D8E-802C-2C0A903EF9CEQ41339288-3E265D7E-411B-4EA0-B7FE-F6974C9996E0Q41672565-CBB2081F-7D37-4B1F-8966-4D8672328F88Q43169980-62F2A2C5-ACBB-4AFF-A1F6-06E459A26202Q44453209-261B693C-3BF7-4E48-8F55-FFEEDE4EA5CDQ45074104-9C393F8D-1353-4480-A70B-278673BC4219Q48510469-407DD9FA-3825-46A9-8320-9E537E225F27Q49662589-E19BAF83-2AE0-4573-BD84-0861A34DC335Q50009608-051890E7-7BFD-4DCE-AD4D-ED54F047BD38Q50157056-9251C95E-770B-4006-A837-892C7F208E1EQ50935891-537D5F98-C3D8-42F4-BEF9-FF8ED8564D6DQ53794087-95DC4000-3881-4999-8E6B-0F1358B9245FQ53810482-74BE6DF3-449E-44BC-AF14-C171D53954C8Q87692438-58DC032C-E670-4603-94D6-0686D94729CD
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Samanta Salvi
@ast
Samanta Salvi
@en
Samanta Salvi
@es
Samanta Salvi
@nl
type
label
Samanta Salvi
@ast
Samanta Salvi
@en
Samanta Salvi
@es
Samanta Salvi
@nl
prefLabel
Samanta Salvi
@ast
Samanta Salvi
@en
Samanta Salvi
@es
Samanta Salvi
@nl
P106
P1153
55620670700
P31
P496
0000-0002-9584-3021